Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo
The therapeutic options for patients with relapsed or metastatic myxoid liposarcoma (MLS) remain scarce and there is currently no targeted therapy available. Inhibition of the HSP90 family of chaperones has been suggested as a possible therapeutic option for patients with MLS. However, the clinical...
Main Authors: | Christoffer Vannas, Lisa Andersson, Soheila Dolatabadi, Parmida Ranji, Malin Lindén, Emma Jonasson, Anders Ståhlberg, Henrik Fagman, Pierre Åman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/3/624 |
Similar Items
-
Histopathological Features of Myxoid Pleomorphic Liposarcoma in an African Pygmy Hedgehog (<i>Atelerix Albiventris</i>)
by: Eun-Joo Lee, et al.
Published: (2022-11-01) -
Identification of Distinct and Common Subpopulations of Myxoid Liposarcoma and Ewing Sarcoma Cells Using Self-Organizing Maps
by: Amin Forootan, et al.
Published: (2023-01-01) -
Prognostic factors of patients with extremity myxoid liposarcomas after surgery
by: Jiaqi Wu, et al.
Published: (2019-03-01) -
Myxoid Liposarcoma of the Breast Mimicking Phyllodes Tumor: A Case Report
by: Se Jin Lee, et al.
Published: (2023-07-01) -
Primary High-Grade Myxoid Liposarcoma of the Extremities: Prognostic Factors and Metastatic Pattern
by: Gianmarco Tuzzato, et al.
Published: (2022-05-01)